Methods to treat neurological diseases
Disclosed is a method of treating a subject who has a neurological disease. The neurological disease may be associated with altered C9ORF72 protein activity. In one aspect, the method includes a step of administering an effective dose of a pharmaceutical composition to a subject in need thereof, thereby rescuing the defects associated with altered C9ORF72 protein activity. Also described are methods for identifying a compound for inhibiting motor neuron degeneration.
1. A method of treating a subject having amyotrophic lateral sclerosis or frontotemporal dementia, comprising:
administering to the subject an effective dose of a PIKFYVE kinase inhibitor selected from the croup consisting of apilimod and YM201636,
wherein the treatment results in an alleviation, reduction, amelioration or improvement in the subject's condition,
and wherein the subject has reduced C9ORF72 gene activity.
2. The method of claim 1 , wherein the subject's C9ORF72 gene comprises a (GGGGCC) n repeat expansion located between exons 1a and 1b of the C9ORF72 gene, wherein n is an integer greater than 25.
3. The method of claim 2 , wherein the subject is haploinsufficient for the C9ORF72 gene.
4. The method of claim 3 , wherein the haploinsufficiency results in a 50% or greater reduction in C9ORF72 protein activity.
5. The method of claim 2 , wherein the C9ORF72 gene product comprises a dipeptide repeat resulting from the (GGGGCC) n expansion.
6. The method of claim 5 , wherein the dipeptide repeat is cytotoxic.
7. The method of claim 2 , wherein the expansion is a gain-of-function or loss-of function mutation.
8. The method of claim 1 , wherein the amyotrophic lateral sclerosis or frontotemporal dementia are associated with neuronal hyperexcitability.